<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04123132</url>
  </required_header>
  <id_info>
    <org_study_id>08090081DEB</org_study_id>
    <nct_id>NCT04123132</nct_id>
  </id_info>
  <brief_title>Evaluation of Kinesophobia in Patients With Metabolic Syndrome</brief_title>
  <official_title>Evaluation of Kinesophobia in Patients With Metabolic Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erol Olcok Corum Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Erol Olcok Corum Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Metabolic syndrome (MS) is a public health problem characterized by central obesity,
      increased blood pressure and triglyceride levels, decreased blood HDL levels and the presence
      of insulin resistance (1).Kinesiophobia is a fear of irrational movement that develops
      because of its belief in susceptibility to injury and is associated with low levels of
      physical activity. Considering that exercise improves metabolic processes in people with MS,
      we aimed to evaluate the presence of kinesophobia in patients with MS.

      Patients aged 45-65 years diagnosed with metabolic syndrome and healthy controls will be
      included in the study. Patients with rheumatic and neurological diseases,history of trauma,
      gonarthrosis, lumbar disc hernia, previous fractures, fibromyalgia and those who have
      experienced pain for the last week will be excluded. The participants will be filled in the
      Short Form-36 (SF-36), the Hospital Anxiety and Depression Scale, and the Tampa Kinesiophobia
      Scale. 48 patients with MS and 48 healthy participants will be included in the study.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 25, 2019</start_date>
  <completion_date type="Anticipated">February 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Tampa Kinesiophobia Scale</measure>
    <time_frame>3 months</time_frame>
    <description>People takes between 17-68 total a score. The score of the person shows high kinesiophobia on the scale</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">96</enrollment>
  <condition>Kinesiophobia</condition>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Patients with metabolic syndrome</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Kinesiophobia</intervention_name>
    <description>The presence of kinesiofobia in patients with metabolic syndrome</description>
    <arm_group_label>Patients with metabolic syndrome</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        45-65 years old men and female with metabolic syndrome and healthy controls
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with metabolic syndrome

        Exclusion Criteria:

          -  Patients with rheumatic disease

          -  Patients with neurologic disease

          -  Patients with history of trauma

          -  Patients with gonartrosis

          -  Pateints with fibromialgia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Dilek E Büyükşireci</last_name>
    <phone>+905439196253</phone>
    <email>dilekeker55@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dilek Eker Büyükşireci</name>
      <address>
        <city>Çorum</city>
        <state>Central Anatolia</state>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dilek E Büyükşireci</last_name>
      <phone>5439196253</phone>
      <email>dilekeker55@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Dilek E Büyükşireci</last_name>
      <phone>+905439196253</phone>
      <email>dilekeker55@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>October 9, 2019</study_first_submitted>
  <study_first_submitted_qc>October 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 10, 2019</study_first_posted>
  <last_update_submitted>January 8, 2020</last_update_submitted>
  <last_update_submitted_qc>January 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Erol Olcok Corum Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Dilek Eker Büyükşireci</investigator_full_name>
    <investigator_title>Specialist doctor</investigator_title>
  </responsible_party>
  <keyword>kinesiophobia</keyword>
  <keyword>metabolic syndrome</keyword>
  <keyword>exercise</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

